# Interferon-Induced Gene Expression in Liver Cells and Peripheral Blood Lymphocytes

> **NCT00324389** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 2 (—)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** Interferon alpha

## Key facts

- **NCT ID:** NCT00324389
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** —
- **Final completion:** 2006-06
- **Target enrollment:** 2 (—)
- **Last updated:** 2010-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00324389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00324389, "Interferon-Induced Gene Expression in Liver Cells and Peripheral Blood Lymphocytes". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00324389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*